LuminUltra has partnered with the Greater Toronto Airports Authority (GTAA) to perform wastewater surveillance testing at Pearson International Airport.... Read More
Hach®, a global leader in water analysis and LuminUltra, a global leader in biological diagnostic testing, have partnered to offer the world’s first rapid, on-site testing solution for the... Read More
The Greater Toronto Airport Authority announced that starting March 1 it will use LuminUltra’s game-changing rapid, portable COVID-19 qPCR testing solution on-site at Pearson International Airport, as part of... Read More
Universal PropTech Inc. (TSXV: UPI) is pleased to announce that is has entered into an agreement with LuminUltra Technologies Ltd. to deploy LuminUltra’s GeneCount® Rapid SARS-CoV-2 surface testing solution... Read More
Researchers across Nova Scotia are launching a project aimed at detecting the presence of the virus that causes COVID-19 in human wastewater, helping to identify the potential presence of... Read More
Vancouver, B.C. – Dec. 14, 2020 – Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia... Read More
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens... Read More
Partnership brings together leaders in their respective fields to advocate for an innovative, science-based approach to pandemic management CANADA – Nov. 18, 2020 – Biotechnology leader LuminUltra has partnered with The Infection Prevention Strategy (TIPS) in the fight against COVID-19 to provide... Read More
LuminUltra has filed a patent for the first complete, rapid, and on-site COVID-19 wastewater testing solution that will make non-invasive community health assessment far more accessible to both the... Read More
The GeneCount® COVID-19 RT-qPCR Assay Kit has been submitted to the U.S. FDA for Emergency Use Authorization and to Health Canada for an Interim Order.... Read More
NGen has announced $3.5 million in project funding in support of Canada’s COVID-19 response, which includes support for LuminUltra's scale-up.... Read More
Until a COVID-19 Vaccine is Available, Widespread Environmental Testing for SARS-CoV-2, Coupled with Effective Disinfection Regimen, Shortens Path to Preserving Public Confidence and Enabling Facilities to Remain Open Amidst... Read More
April 15th, 2020 Fredericton, New Brunswick – Canadian biotechnology leader LuminUltra today announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government... Read More
LuminUltra is committed to keeping you up-to-date on our response during this ever-changing time. Latest updates here.... Read More
Update your browser to view this website correctly. Update my browser now
